Traws Pharma Inc TRAW

Healthcare

Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a Mpro protease inhibitor for COVID19. Narazaciclib is a cyclin-dependent kinases (CDK) 4/6 inhibitor for low-grade endometrioid endometrial cancer (LGEEC). Narazaciclib’s mechanism of action in LGEEC is validated by phase II studies with other approved CDK4/6 inhibitors: palbociclib, ribociclib, and abemaciclib. Narazaciclib is in phase I/IIa study to define the Phase II dose (RP2D).

NDAQ:TRAW - Post by User

Traws Pharma Inc > What’s going on with ONTX stock?

<< Previous

Bullboard Posts

Next >>

Comment by Mukulu20on May 09, 2022 7:27pm

122 Views

Post# 34668913

RE:RE:RE:RE:What’s going on with ONTX stock?

Shameful management. Extremely self serving. They have decimated so many innocent shareholders. They must be held accountable for their sorcery. Playing with hard earned money of ordinary shareholders. They better have some substance and good results to report.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals